Other investigations have concluded that necroptosis/RIPK3 has a role in cancer mitigation and control32,92,159–164; it has also been suggested that necroptosis-mediated inflammation and cell death may alternatively contribute to tumorigenesis and an immunosuppressive tumor microenvironment163,165–167. The gene discussed is RIPK3; the disease is neoplasm.